NNZ2591 is the jewel in the crown here! Not limited to the 4 ailments already progressing well and "designed to be more stable" and "correcting impairment, but not impacting normal cells". No real current share price value is yet attributed to NNZ591 - it is all trofinetide and rowr at the moment IMHO. The rocket is about to be launched and it is not powered by DAYBUE/trofinetide.... that is just the truck delivering the rocket to the launch pad! The rocket fuel is NNZ2591.
Ann: Investor Presentation, 14 March 2023, page-4
-
- There are more pages in this discussion • 142 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.52 |
Change
0.660(3.32%) |
Mkt cap ! $2.622B | |||
| Open | High | Low | Value | Volume |
| $20.00 | $20.66 | $19.94 | $6.431M | 315.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1024 | $20.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.53 | 285 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |